Oklo Rises on Nuclear Initiative as Insiders Sold $55M
NEW YORK, July 22 —
Oklo Inc. shares rose Tuesday alongside X-Energy on reports of a federal nuclear reactor initiative, landing the stock in multiple biggest-mover round-ups through the session. The reported catalyst, a "federal nuclear role" attributed to both companies, has yet to appear in any SEC filing or confirmed press release. What has appeared in filings: three executives recording $54.96 million in net sales over the past 90 days, at prices well above where Oklo trades today.
- $54.96 million in net insider sales over the trailing 90 days, zero purchases, per Form 4 filings
- CEO Jacob DeWitte and COO Caroline Cochran each sold 200,000 shares on July 1, 2026, at $52.30 to $53.71 per share, for proceeds of approximately $10.59 million apiece, per Form 4 filings
- Current price: $44.13, below the July 1 sale range of $52.30 to $53.71 and well below the June 1 range of $64.99 to $70.45
The Headline vs. the Deal
Nuclear power has a genuine policy tailwind. Data center electricity demand has made small modular reactors newly relevant in Washington, and Oklo is directly positioned to benefit if federal procurement materializes. But Tuesday's catalyst is reportedly an initiative, not a contract. Per news accounts, Oklo and X-Energy rose on "reported" federal engagement, with no disclosed terms, counterparties, or timelines. The market is pricing in a deal that has not been confirmed in any public filing.
The Selling Pattern
The insider transaction record over the prior 60 days is less ambiguous. On June 1, CEO DeWitte sold shares across eight open-market tranches at $64.99 to $70.45, with the single largest block of 60,000 shares at $68.29 generating $4.1 million in proceeds. COO Caroline Cochran executed eight transactions the same day with identical block sizes in the same price range. CFO Richard Craig Bealmear added three tranches at $65.00 to $69.42, collecting approximately $5 million.
On July 1, the pattern repeated. DeWitte and Cochran each sold exactly 200,000 shares across four transactions at $52.30 to $53.71 per share, for proceeds of approximately $10.59 million apiece. Bealmear exercised options at $3.18 and sold the resulting 16,321 shares at $52.63, adding $859,000. Same co-founders, same block sizes, same dates, twice. Zero purchases in the 90-day window, per Form 4 filings.
The coordination between the two co-founders is the detail worth sitting with. Identical block sizes across both June 1 and July 1 tranches suggests a structured program rather than opportunistic selling. That is not inherently sinister. But it does mean the $21.2 million that cleared on July 1 alone was not impulsive.
The Price Gap
Insider sales carry routine explanations: tax planning, diversification, pre-scheduled 10b5-1 programs. The filings do not establish intent. The arithmetic, though, is plain. The co-founders cleared $65 to $70 on June 1. Oklo is at $44.13. They cleared $52 to $54 on July 1. Oklo is still at $44.13. Both tranches landed above where shares trade today, and neither price level has been revisited since the sales occurred. The executives with the most direct view of the company's commercial pipeline were consistent sellers into every period of strength.
What Changes This
The nuclear buildout thesis is not theater. A confirmed federal procurement, with disclosed terms, a named counterparty, and a contract value filed with the SEC, would represent a genuine commercial milestone and would warrant reassessing Oklo at any price. That is the filing to watch.
Until it arrives, Tuesday's rally reflects the narrative running ahead of its evidence base. Investors buying the move are effectively pricing in a deal the company's own founders did not hold shares to capture. Whether the reported initiative becomes a binding agreement is the single question that changes this picture. For a fuller look at Oklo's fundamentals, run the free Oklo Inc. deep-dive →
Basis Report does not hold positions in securities discussed. This is not investment advice.
Frequently Asked Questions
Why is Oklo stock rising today?
Oklo shares rose on July 22, 2026, alongside X-Energy on reports of a federal nuclear reactor initiative. News outlets attributed the move to a "reported Federal Nuclear Role," though as of Tuesday, no SEC filing or confirmed press release had established the terms, parties, or status of any federal agreement.
How much have Oklo insiders sold recently?
Per Form 4 filings, Oklo insiders recorded net sales of $54.96 million over the trailing 90 days with zero purchases. CEO Jacob DeWitte and COO Caroline Cochran each sold 200,000 shares on July 1, 2026, generating combined proceeds of roughly $21.2 million at prices ranging from $52.30 to $53.71 per share.
Did Oklo sign a federal government contract?
No confirmed contract has appeared in public SEC filings as of July 22, 2026. The rally was attributed to reports of a "federal nuclear role," but no disclosed agreement with confirmed terms or counterparties has been filed. The catalyst remains a news report, not a binding commitment.
What is Oklo's stock price today?
Oklo trades at $44.13. That sits below the $52.30 to $53.71 range at which the co-founders sold on July 1, 2026, and well below the $64.99 to $70.45 range of their June 1, 2026 sales — meaning both recent insider tranches cleared at prices the stock has not revisited.
Is Oklo stock a buy right now?
The current rally is driven by unconfirmed policy reports rather than a filed agreement. The co-founders' coordinated sales totaling over $21 million on July 1 alone, at prices roughly 18% above today's level, represent a meaningful contrary signal. A confirmed and filed federal contract would change the calculus; until that appears, the evidence base for the rally is thin.
Sources & filings